Latest Nyrada (ASX:NYR) News
Page 1
Page 1 of 3
Healthcare Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Nyrada expands Xolatryp trial as FDA feedback clears path to 2027 IND
19 Oct 2026
Healthcare Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Nyrada gets supportive FDA feedback for Xolatryp Phase IIa pathway
13 Oct 2026
Nyrada lodges prospectus for 10.74 million free options at $0.93
12 Oct 2026
Market Wrap - Week 39 (21 Sept -> 25 Sept) 2026
26 Sept 2026
Healthcare Wrap - Week 39 (21 Sept -> 25 Sept) 2026
26 Sept 2026
Nyrada secures AU$12 million to fund Xolatryp trial and expand biotech pipeline
21 Sept 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Nyrada Doses First Patient in Xolatryp Phase IIa Trial, Secures US Patent Allowance
27 July 2026
Healthcare Wrap - Week 16 (13 Apr -> 17 Apr) 2026
18 Apr 2026
Nyrada Advances Xolatryp Phase IIa Trial with AU$6.74M Cash and Expanded Oncology Research
15 Apr 2026